 | • レポートコード：MRC2-11QY12030 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、127ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はゲノムバイオマーカーのグローバル市場について調査・分析したレポートです。種類別（腫瘍、心臓病、神経、腎臓）市場規模、用途別（病院、診断・研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ゲノムバイオマーカーの競争状況、市場シェア ・世界のゲノムバイオマーカー市場：種類別市場規模 2015年-2020年（腫瘍、心臓病、神経、腎臓） ・世界のゲノムバイオマーカー市場：種類別市場規模予測 2021年-2026年（腫瘍、心臓病、神経、腎臓） ・世界のゲノムバイオマーカー市場：用途別市場規模 2015年-2020年（病院、診断・研究所） ・世界のゲノムバイオマーカー市場：用途別市場規模予測 2021年-2026年（病院、診断・研究所） ・北米のゲノムバイオマーカー市場分析：米国、カナダ ・ヨーロッパのゲノムバイオマーカー市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのゲノムバイオマーカー市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のゲノムバイオマーカー市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのゲノムバイオマーカー市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bio-Rad、Beckman Coulter、Myriad Genetics、Thermo Fisher Scientific、Roche、QIAGEN、Epigenomics、Almac、Pfizer、Human Longevity、ValiRx、Personalis、Eagle Genomics、Empire Genomics、Agilent、Illumina ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
A measurable DNA and/or RNA characteristic that is an indicator of normal biologic processes, pathogenic processes, and/or response to therapeutic or other interventions.
Major factors contributing to the growth of the global genomic biomarker market include increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, neurological disorders and others. Other driving factors include increasing research and investment in the field of genomic biomarkers and use of genomic biomarker services for the enhancement of drug development pipelines.
Market Analysis and Insights: Global Genomic Biomarker Market
The global Genomic Biomarker market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Genomic Biomarker Scope and Market Size
Genomic Biomarker market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Genomic Biomarker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Bio-Rad
Beckman Coulter
Myriad Genetics
Thermo Fisher Scientific
Roche
QIAGEN
Epigenomics
Almac
Pfizer
Human Longevity
ValiRx
Personalis
Eagle Genomics
Empire Genomics
Agilent
Illumina
Market segment by Type, the product can be split into
Oncology
Cardiology
Neurology
Nephrology
Market segment by Application, split into
Hospitals
Diagnostic and research laboratories
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Genomic Biomarker Revenue
1.4 Market by Type
1.4.1 Global Genomic Biomarker Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oncology
1.4.3 Cardiology
1.4.4 Neurology
1.4.5 Nephrology
1.5 Market by Application
1.5.1 Global Genomic Biomarker Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Diagnostic and research laboratories
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Genomic Biomarker Market Perspective (2015-2026)
2.2 Global Genomic Biomarker Growth Trends by Regions
2.2.1 Genomic Biomarker Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Genomic Biomarker Historic Market Share by Regions (2015-2020)
2.2.3 Genomic Biomarker Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Genomic Biomarker Market Growth Strategy
2.3.6 Primary Interviews with Key Genomic Biomarker Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Genomic Biomarker Players by Market Size
3.1.1 Global Top Genomic Biomarker Players by Revenue (2015-2020)
3.1.2 Global Genomic Biomarker Revenue Market Share by Players (2015-2020)
3.1.3 Global Genomic Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Genomic Biomarker Market Concentration Ratio
3.2.1 Global Genomic Biomarker Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Genomic Biomarker Revenue in 2019
3.3 Genomic Biomarker Key Players Head office and Area Served
3.4 Key Players Genomic Biomarker Product Solution and Service
3.5 Date of Enter into Genomic Biomarker Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Genomic Biomarker Historic Market Size by Type (2015-2020)
4.2 Global Genomic Biomarker Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Genomic Biomarker Market Size by Application (2015-2020)
5.2 Global Genomic Biomarker Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Genomic Biomarker Market Size (2015-2020)
6.2 Genomic Biomarker Key Players in North America (2019-2020)
6.3 North America Genomic Biomarker Market Size by Type (2015-2020)
6.4 North America Genomic Biomarker Market Size by Application (2015-2020)
7 Europe
7.1 Europe Genomic Biomarker Market Size (2015-2020)
7.2 Genomic Biomarker Key Players in Europe (2019-2020)
7.3 Europe Genomic Biomarker Market Size by Type (2015-2020)
7.4 Europe Genomic Biomarker Market Size by Application (2015-2020)
8 China
8.1 China Genomic Biomarker Market Size (2015-2020)
8.2 Genomic Biomarker Key Players in China (2019-2020)
8.3 China Genomic Biomarker Market Size by Type (2015-2020)
8.4 China Genomic Biomarker Market Size by Application (2015-2020)
9 Japan
9.1 Japan Genomic Biomarker Market Size (2015-2020)
9.2 Genomic Biomarker Key Players in Japan (2019-2020)
9.3 Japan Genomic Biomarker Market Size by Type (2015-2020)
9.4 Japan Genomic Biomarker Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Genomic Biomarker Market Size (2015-2020)
10.2 Genomic Biomarker Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Genomic Biomarker Market Size by Type (2015-2020)
10.4 Southeast Asia Genomic Biomarker Market Size by Application (2015-2020)
11 India
11.1 India Genomic Biomarker Market Size (2015-2020)
11.2 Genomic Biomarker Key Players in India (2019-2020)
11.3 India Genomic Biomarker Market Size by Type (2015-2020)
11.4 India Genomic Biomarker Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Genomic Biomarker Market Size (2015-2020)
12.2 Genomic Biomarker Key Players in Central & South America (2019-2020)
12.3 Central & South America Genomic Biomarker Market Size by Type (2015-2020)
12.4 Central & South America Genomic Biomarker Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Bio-Rad
13.1.1 Bio-Rad Company Details
13.1.2 Bio-Rad Business Overview
13.1.3 Bio-Rad Genomic Biomarker Introduction
13.1.4 Bio-Rad Revenue in Genomic Biomarker Business (2015-2020))
13.1.5 Bio-Rad Recent Development
13.2 Beckman Coulter
13.2.1 Beckman Coulter Company Details
13.2.2 Beckman Coulter Business Overview
13.2.3 Beckman Coulter Genomic Biomarker Introduction
13.2.4 Beckman Coulter Revenue in Genomic Biomarker Business (2015-2020)
13.2.5 Beckman Coulter Recent Development
13.3 Myriad Genetics
13.3.1 Myriad Genetics Company Details
13.3.2 Myriad Genetics Business Overview
13.3.3 Myriad Genetics Genomic Biomarker Introduction
13.3.4 Myriad Genetics Revenue in Genomic Biomarker Business (2015-2020)
13.3.5 Myriad Genetics Recent Development
13.4 Thermo Fisher Scientific
13.4.1 Thermo Fisher Scientific Company Details
13.4.2 Thermo Fisher Scientific Business Overview
13.4.3 Thermo Fisher Scientific Genomic Biomarker Introduction
13.4.4 Thermo Fisher Scientific Revenue in Genomic Biomarker Business (2015-2020)
13.4.5 Thermo Fisher Scientific Recent Development
13.5 Roche
13.5.1 Roche Company Details
13.5.2 Roche Business Overview
13.5.3 Roche Genomic Biomarker Introduction
13.5.4 Roche Revenue in Genomic Biomarker Business (2015-2020)
13.5.5 Roche Recent Development
13.6 QIAGEN
13.6.1 QIAGEN Company Details
13.6.2 QIAGEN Business Overview
13.6.3 QIAGEN Genomic Biomarker Introduction
13.6.4 QIAGEN Revenue in Genomic Biomarker Business (2015-2020)
13.6.5 QIAGEN Recent Development
13.7 Epigenomics
13.7.1 Epigenomics Company Details
13.7.2 Epigenomics Business Overview
13.7.3 Epigenomics Genomic Biomarker Introduction
13.7.4 Epigenomics Revenue in Genomic Biomarker Business (2015-2020)
13.7.5 Epigenomics Recent Development
13.8 Almac
13.8.1 Almac Company Details
13.8.2 Almac Business Overview
13.8.3 Almac Genomic Biomarker Introduction
13.8.4 Almac Revenue in Genomic Biomarker Business (2015-2020)
13.8.5 Almac Recent Development
13.9 Pfizer
13.9.1 Pfizer Company Details
13.9.2 Pfizer Business Overview
13.9.3 Pfizer Genomic Biomarker Introduction
13.9.4 Pfizer Revenue in Genomic Biomarker Business (2015-2020)
13.9.5 Pfizer Recent Development
13.10 Human Longevity
13.10.1 Human Longevity Company Details
13.10.2 Human Longevity Business Overview
13.10.3 Human Longevity Genomic Biomarker Introduction
13.10.4 Human Longevity Revenue in Genomic Biomarker Business (2015-2020)
13.10.5 Human Longevity Recent Development
13.11 ValiRx
10.11.1 ValiRx Company Details
10.11.2 ValiRx Business Overview
10.11.3 ValiRx Genomic Biomarker Introduction
10.11.4 ValiRx Revenue in Genomic Biomarker Business (2015-2020)
10.11.5 ValiRx Recent Development
13.12 Personalis
10.12.1 Personalis Company Details
10.12.2 Personalis Business Overview
10.12.3 Personalis Genomic Biomarker Introduction
10.12.4 Personalis Revenue in Genomic Biomarker Business (2015-2020)
10.12.5 Personalis Recent Development
13.13 Eagle Genomics
10.13.1 Eagle Genomics Company Details
10.13.2 Eagle Genomics Business Overview
10.13.3 Eagle Genomics Genomic Biomarker Introduction
10.13.4 Eagle Genomics Revenue in Genomic Biomarker Business (2015-2020)
10.13.5 Eagle Genomics Recent Development
13.14 Empire Genomics
10.14.1 Empire Genomics Company Details
10.14.2 Empire Genomics Business Overview
10.14.3 Empire Genomics Genomic Biomarker Introduction
10.14.4 Empire Genomics Revenue in Genomic Biomarker Business (2015-2020)
10.14.5 Empire Genomics Recent Development
13.15 Agilent
10.15.1 Agilent Company Details
10.15.2 Agilent Business Overview
10.15.3 Agilent Genomic Biomarker Introduction
10.15.4 Agilent Revenue in Genomic Biomarker Business (2015-2020)
10.15.5 Agilent Recent Development
13.16 Illumina
10.16.1 Illumina Company Details
10.16.2 Illumina Business Overview
10.16.3 Illumina Genomic Biomarker Introduction
10.16.4 Illumina Revenue in Genomic Biomarker Business (2015-2020)
10.16.5 Illumina Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Genomic Biomarker Key Market Segments
Table 2. Key Players Covered: Ranking by Genomic Biomarker Revenue
Table 3. Ranking of Global Top Genomic Biomarker Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Genomic Biomarker Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oncology
Table 6. Key Players of Cardiology
Table 7. Key Players of Neurology
Table 8. Key Players of Nephrology
Table 9. Global Genomic Biomarker Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Genomic Biomarker Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Genomic Biomarker Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Genomic Biomarker Market Share by Regions (2015-2020)
Table 13. Global Genomic Biomarker Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Genomic Biomarker Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Genomic Biomarker Market Growth Strategy
Table 19. Main Points Interviewed from Key Genomic Biomarker Players
Table 20. Global Genomic Biomarker Revenue by Players (2015-2020) (Million US$)
Table 21. Global Genomic Biomarker Market Share by Players (2015-2020)
Table 22. Global Top Genomic Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genomic Biomarker as of 2019)
Table 23. Global Genomic Biomarker by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Genomic Biomarker Product Solution and Service
Table 26. Date of Enter into Genomic Biomarker Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Genomic Biomarker Market Size by Type (2015-2020) (Million US$)
Table 29. Global Genomic Biomarker Market Size Share by Type (2015-2020)
Table 30. Global Genomic Biomarker Revenue Market Share by Type (2021-2026)
Table 31. Global Genomic Biomarker Market Size Share by Application (2015-2020)
Table 32. Global Genomic Biomarker Market Size by Application (2015-2020) (Million US$)
Table 33. Global Genomic Biomarker Market Size Share by Application (2021-2026)
Table 34. North America Key Players Genomic Biomarker Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Genomic Biomarker Market Share (2019-2020)
Table 36. North America Genomic Biomarker Market Size by Type (2015-2020) (Million US$)
Table 37. North America Genomic Biomarker Market Share by Type (2015-2020)
Table 38. North America Genomic Biomarker Market Size by Application (2015-2020) (Million US$)
Table 39. North America Genomic Biomarker Market Share by Application (2015-2020)
Table 40. Europe Key Players Genomic Biomarker Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Genomic Biomarker Market Share (2019-2020)
Table 42. Europe Genomic Biomarker Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Genomic Biomarker Market Share by Type (2015-2020)
Table 44. Europe Genomic Biomarker Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Genomic Biomarker Market Share by Application (2015-2020)
Table 46. China Key Players Genomic Biomarker Revenue (2019-2020) (Million US$)
Table 47. China Key Players Genomic Biomarker Market Share (2019-2020)
Table 48. China Genomic Biomarker Market Size by Type (2015-2020) (Million US$)
Table 49. China Genomic Biomarker Market Share by Type (2015-2020)
Table 50. China Genomic Biomarker Market Size by Application (2015-2020) (Million US$)
Table 51. China Genomic Biomarker Market Share by Application (2015-2020)
Table 52. Japan Key Players Genomic Biomarker Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Genomic Biomarker Market Share (2019-2020)
Table 54. Japan Genomic Biomarker Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Genomic Biomarker Market Share by Type (2015-2020)
Table 56. Japan Genomic Biomarker Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Genomic Biomarker Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Genomic Biomarker Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Genomic Biomarker Market Share (2019-2020)
Table 60. Southeast Asia Genomic Biomarker Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Genomic Biomarker Market Share by Type (2015-2020)
Table 62. Southeast Asia Genomic Biomarker Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Genomic Biomarker Market Share by Application (2015-2020)
Table 64. India Key Players Genomic Biomarker Revenue (2019-2020) (Million US$)
Table 65. India Key Players Genomic Biomarker Market Share (2019-2020)
Table 66. India Genomic Biomarker Market Size by Type (2015-2020) (Million US$)
Table 67. India Genomic Biomarker Market Share by Type (2015-2020)
Table 68. India Genomic Biomarker Market Size by Application (2015-2020) (Million US$)
Table 69. India Genomic Biomarker Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Genomic Biomarker Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Genomic Biomarker Market Share (2019-2020)
Table 72. Central & South America Genomic Biomarker Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Genomic Biomarker Market Share by Type (2015-2020)
Table 74. Central & South America Genomic Biomarker Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Genomic Biomarker Market Share by Application (2015-2020)
Table 76. Bio-Rad Company Details
Table 77. Bio-Rad Business Overview
Table 78. Bio-Rad Product
Table 79. Bio-Rad Revenue in Genomic Biomarker Business (2015-2020) (Million US$)
Table 80. Bio-Rad Recent Development
Table 81. Beckman Coulter Company Details
Table 82. Beckman Coulter Business Overview
Table 83. Beckman Coulter Product
Table 84. Beckman Coulter Revenue in Genomic Biomarker Business (2015-2020) (Million US$)
Table 85. Beckman Coulter Recent Development
Table 86. Myriad Genetics Company Details
Table 87. Myriad Genetics Business Overview
Table 88. Myriad Genetics Product
Table 89. Myriad Genetics Revenue in Genomic Biomarker Business (2015-2020) (Million US$)
Table 90. Myriad Genetics Recent Development
Table 91. Thermo Fisher Scientific Company Details
Table 92. Thermo Fisher Scientific Business Overview
Table 93. Thermo Fisher Scientific Product
Table 94. Thermo Fisher Scientific Revenue in Genomic Biomarker Business (2015-2020) (Million US$)
Table 95. Thermo Fisher Scientific Recent Development
Table 96. Roche Company Details
Table 97. Roche Business Overview
Table 98. Roche Product
Table 99. Roche Revenue in Genomic Biomarker Business (2015-2020) (Million US$)
Table 100. Roche Recent Development
Table 101. QIAGEN Company Details
Table 102. QIAGEN Business Overview
Table 103. QIAGEN Product
Table 104. QIAGEN Revenue in Genomic Biomarker Business (2015-2020) (Million US$)
Table 105. QIAGEN Recent Development
Table 106. Epigenomics Company Details
Table 107. Epigenomics Business Overview
Table 108. Epigenomics Product
Table 109. Epigenomics Revenue in Genomic Biomarker Business (2015-2020) (Million US$)
Table 110. Epigenomics Recent Development
Table 111. Almac Business Overview
Table 112. Almac Product
Table 113. Almac Company Details
Table 114. Almac Revenue in Genomic Biomarker Business (2015-2020) (Million US$)
Table 115. Almac Recent Development
Table 116. Pfizer Company Details
Table 117. Pfizer Business Overview
Table 118. Pfizer Product
Table 119. Pfizer Revenue in Genomic Biomarker Business (2015-2020) (Million US$)
Table 120. Pfizer Recent Development
Table 121. Human Longevity Company Details
Table 122. Human Longevity Business Overview
Table 123. Human Longevity Product
Table 124. Human Longevity Revenue in Genomic Biomarker Business (2015-2020) (Million US$)
Table 125. Human Longevity Recent Development
Table 126. ValiRx Company Details
Table 127. ValiRx Business Overview
Table 128. ValiRx Product
Table 129. ValiRx Revenue in Genomic Biomarker Business (2015-2020) (Million US$)
Table 130. ValiRx Recent Development
Table 131. Personalis Company Details
Table 132. Personalis Business Overview
Table 133. Personalis Product
Table 134. Personalis Revenue in Genomic Biomarker Business (2015-2020) (Million US$)
Table 135. Personalis Recent Development
Table 136. Eagle Genomics Company Details
Table 137. Eagle Genomics Business Overview
Table 138. Eagle Genomics Product
Table 139. Eagle Genomics Revenue in Genomic Biomarker Business (2015-2020) (Million US$)
Table 140. Eagle Genomics Recent Development
Table 141. Empire Genomics Company Details
Table 142. Empire Genomics Business Overview
Table 143. Empire Genomics Product
Table 144. Empire Genomics Revenue in Genomic Biomarker Business (2015-2020) (Million US$)
Table 145. Empire Genomics Recent Development
Table 146. Agilent Company Details
Table 147. Agilent Business Overview
Table 148. Agilent Product
Table 149. Agilent Revenue in Genomic Biomarker Business (2015-2020) (Million US$)
Table 150. Agilent Recent Development
Table 151. Illumina Company Details
Table 152. Illumina Business Overview
Table 153. Illumina Product
Table 154. Illumina Revenue in Genomic Biomarker Business (2015-2020) (Million US$)
Table 155. Illumina Recent Development
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genomic Biomarker Market Share by Type: 2020 VS 2026
Figure 2. Oncology Features
Figure 3. Cardiology Features
Figure 4. Neurology Features
Figure 5. Nephrology Features
Figure 6. Global Genomic Biomarker Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Diagnostic and research laboratories Case Studies
Figure 9. Genomic Biomarker Report Years Considered
Figure 10. Global Genomic Biomarker Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Genomic Biomarker Market Share by Regions: 2020 VS 2026
Figure 12. Global Genomic Biomarker Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Genomic Biomarker Market Share by Players in 2019
Figure 15. Global Top Genomic Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genomic Biomarker as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Genomic Biomarker Revenue in 2019
Figure 17. North America Genomic Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Genomic Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Genomic Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Genomic Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Genomic Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Genomic Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Genomic Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
診断バイオマーカーの世界市場（～2026年） Biomarkers have its property and the biological functions or molecules that are detected in various vitals of the body such as blood and other fluids. Further, they are then measured in those parts. They may indicate either normal or diseased processes in the body. Biomarkers are used in various pur…- ゲノム医療の世界市場（～2026年） Market Analysis and Insights: Global Genomic Medicine Market The global Genomic Medicine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Genomic Medicine Scope and Market Size Genomic Medicine market is segmented by Ty…
- ボーカルバイオマーカーの世界市場（～2026年） Vocal patterns have been used by clinical psychologists and psychoanalysts for analyzing personality traits of patients, and helping creation of headway in clinical and medical investigations. Recent breakthroughs in the healthcare sector have led to the development of a unique diagnostic tool known…
- 代謝バイオマーカー検査の世界市場（～2026年） In medicine, a biomarker is a measurable indicator of the severity or presence of some disease state. More generally a biomarker is anything that can be used as an indicator of a particular disease state or some other physiological state of an organism. Biomarkers are useful in a number of ways, inc…
- リキッドバイオプシー用循環バイオマーカーの世界市場（～2026年） Market Analysis and Insights: Global Circulating Biomarker for Liquid Biopsy Market The global Circulating Biomarker for Liquid Biopsy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Circulating Biomarker for Liquid Bi…